---
title: "TIANYU PHARM: Candesartan Cilexetil Tablets have completed drug registration"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/255907950.md"
description: "According to the Zhitong Finance APP, TIANYU PHARM announced that its wholly-owned subsidiary Zhejiang Nuode Pharmaceutical Co., Ltd. (referred to as \"Nuode Pharmaceutical\") recently received the \"Drug Registration Certificate\" for Candesartan Cilexetil Tablets issued by the National Medical Products Administration. Candesartan Cilexetil Tablets are indicated for primary hypertension"
datetime: "2025-09-04T08:12:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/255907950.md)
  - [en](https://longbridge.com/en/news/255907950.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/255907950.md)
---

# TIANYU PHARM: Candesartan Cilexetil Tablets have completed drug registration

According to the Zhitong Finance APP, TIANYU PHARM (300702.SZ) announced that its wholly-owned subsidiary Zhejiang Nuode Pharmaceutical Co., Ltd. (referred to as "Nuode Pharmaceutical") recently received the "Drug Registration Certificate" for Candesartan Cilexetil Tablets issued by the National Medical Products Administration. Candesartan Cilexetil Tablets are indicated for primary hypertension

### Related Stocks

- [300702.CN](https://longbridge.com/en/quote/300702.CN.md)

## Related News & Research

- [FOCUS-As Europe rearms, Italy's fragmented space sector faces a scale test](https://longbridge.com/en/news/296303505.md)
- [CSPC Innovation Pharmaceutical: Biopharma licensing and product launches drove record revenue and profit growth](https://longbridge.com/en/news/296129143.md)
- [SandboxAQ introduces AQPotency for virtual drug screening](https://longbridge.com/en/news/296467103.md)
- [JIC Venture Growth Investments takes minority stake in rocket engine startup Letara](https://longbridge.com/en/news/296418219.md)
- [Curql invests in pet healthcare platform Wagmo](https://longbridge.com/en/news/296396050.md)